Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Aug 4;9(8):e104056.
doi: 10.1371/journal.pone.0104056. eCollection 2014.

Two β-galactosidases from the human isolate Bifidobacterium breve DSM 20213: molecular cloning and expression, biochemical characterization and synthesis of galacto-oligosaccharides

Affiliations

Two β-galactosidases from the human isolate Bifidobacterium breve DSM 20213: molecular cloning and expression, biochemical characterization and synthesis of galacto-oligosaccharides

Sheryl Lozel Arreola et al. PLoS One. .

Abstract

Two β-galactosidases, β-gal I and β-gal II, from Bifidobacterium breve DSM 20213, which was isolated from the intestine of an infant, were overexpressed in Escherichia coli with co-expression of the chaperones GroEL/GroES, purified to electrophoretic homogeneity and biochemically characterized. Both β-gal I and β-gal II belong to glycoside hydrolase family 2 and are homodimers with native molecular masses of 220 and 211 kDa, respectively. The optimum pH and temperature for hydrolysis of the two substrates o-nitrophenyl-β-D-galactopyranoside (oNPG) and lactose were determined at pH 7.0 and 50°C for β-gal I, and at pH 6.5 and 55°C for β-gal II, respectively. The kcat/Km values for oNPG and lactose hydrolysis are 722 and 7.4 mM-1s-1 for β-gal I, and 543 and 25 mM-1s-1 for β-gal II. Both β-gal I and β-gal II are only moderately inhibited by their reaction products D-galactose and D-glucose. Both enzymes were found to be very well suited for the production of galacto-oligosaccharides with total GOS yields of 33% and 44% of total sugars obtained with β-gal I and β-gal II, respectively. The predominant transgalactosylation products are β-D-Galp-(1→6)-D-Glc (allolactose) and β-D-Galp-(1→3)-D-Lac, accounting together for more than 75% and 65% of the GOS formed by transgalactosylation by β-gal I and β-gal II, respectively, indicating that both enzymes have a propensity to synthesize β-(1→6) and β-(1→3)-linked GOS. The resulting GOS mixtures contained relatively high fractions of allolactose, which results from the fact that glucose is a far better acceptor for galactosyl transfer than galactose and lactose, and intramolecular transgalactosylation contributes significantly to the formation of this disaccharide.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. pH (A and B) and temperature (C and D) optimum of β-galactosidase activity for B. breve β-gal I (•) and β-gal II (○) using oNPG (A and C) and lactose (B and D) as substrate.
Values are the mean of two independent experiments and the standard deviation was always less than 5%.
Figure 2
Figure 2. pH stability of the β-galactosidases from B. breve β-gal I (•) and β-gal II (○) incubated at 37°C in Britton-Robinson buffer over a pH range of pH 5.0–9.0 for 4 h (solid lines) and 10 h (dashed lines).
The residual activity was measured after 4(B) and oNPG was used as substrate for the enzyme assay. Values are the mean of two independent experiments and the standard deviation was always less than 5%.
Figure 3
Figure 3. Time course of GOS formation (A) and formation and degradation of GOS during lactose conversion (B) catalyzed by B. breve β-gal I (•) and β-gal II (○).
The reaction was performed at 30°C at an initial lactose concentration of 200 g L−1 in sodium phosphate buffer (pH 6.5) and 1 mM MgCl2 using 1.5 ULac mL−1 . Values are the mean of two independent experiments and the standard deviation was always less than 5%.
Figure 4
Figure 4. Formation and degradation of individual GOS formed by B. breve β-gal I (A) and β-gal II (B) during lactose conversion.
Reaction conditions: initial lactose concentration of 200 g L−1 in 50 mM sodium phosphate buffer (pH 6.5) with 1 mM Mg2+ and 30°C and 1.0 ULac mL−1 β-gal I or 2.5 ULac mL−1 β-gal II. Symbols: (•) D-Galp-(1→6)-D-Glc; (▪) D-Galp-(1→6)-D-Gal; (▴) Galp-(1→3)-D-Gal; (Δ) D-Galp-(1→3)-D-Glc; (□) D-Galp-(1→3)-D-Lac; (○) D-Galp-(1→4)-Lac, (+) D-Galp-(1→6)-D-Lac.
Figure 5
Figure 5. D-Glucose/D-Galactose (solid lines) and GalGlc/GalGal (dashed lines) ratios (A); GalGlc/GalLac (solid lines) and GalGal/GalLac (dashed lines) ratios (B) during lactose conversion by B. breve β-gal I (close symbol) and β-gal II (open symbol).
The reactions were performed at 30°C at an initial lactose concentration of 200 g L−1 in sodium phosphate buffer (pH 6.5) and 1 mM MgCl2 with 1.0 ULac mL−1 β-gal I or 2.5 ULac mL−1 β-gal II.

References

    1. Gibson GR, Roberfroid MB (1995) Dietary modulation of the human colonic microbiota: Introducing the concept of prebiotics. J Nutr 125: 1401–1412. - PubMed
    1. Bouhnik Y, Raskine L, Simoneau G, Vicaut E, Neut C, et al. (2004) The capacity of nondigestible carbohydrates to stimulate fecal bifidobacteria in healthy humans: A double-blind, randomized, placebo-controlled, parallel-group, dose-response relation study. Am J ClinNutr 80: 1658–1664. - PubMed
    1. Matsuki T, Watanabe K, Tanaka R, Fukuda M, Oyaizu H (1999) Distribution of bifidobacterial species in human intestinal microflora examined with 16S rRNA-gene-targeted species-specific primers. Appl Environ Microbiol 65: 4506–4512. - PMC - PubMed
    1. Biavati B, Mattarelli P (2006) The family Bifidobacteriaceae. In: Dworkin M, Falkow S, Rosenberg E, Schleifer KH, Stackebrandt E, editors. The prokaryotes. 3rd ed. New York: Springer. pp. 322–382.
    1. Tanaka R (1995) Clinical effects of bifidobacteria and lactobacilli. In: Fuller R, Heidt PJ, Rusch V, Waaij DVD, editors. Probiotics: prospects of use in opportunistic infections Old Herborn University seminar monograph 8: Institute for Microbiology and Biochemistry, Herborn-Dill, Germany. pp. 141–157.

Publication types

MeSH terms